KaloBios Attempts To Consolidate After Four Volatile Sessions

By: via Benzinga
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) shares are trading higher by $8 at 26.40 in Wednesday's session. The frenzied trading action ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.